Testing a swallowable scope for early detection of Barrett’s esophagus
Part of Cancer, Digestive system clinical trials.
This study checks whether a special swallowable “camera capsule” test done in primary care can find early warning changes called Barrett’s esophagus. If it works well, it could make screening easier for people at risk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult (18 or older)
- You are registered at the study’s primary care clinics (Assembly Row, MGH Broadway Primary Care - Revere, or Pentucket Medical Associates)
- You can give informed consent
- You have no food for 1 hour before the procedure
- You are not pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks whether a special laser-guided method can safely collect tiny tissue samples from the esophagus to help predict how Barrett’s esophagus may turn out. If you have Barrett’s, the results may help doctors better estimate your future risk.
This trial tests a device that collects cells from the esophagus using a swallowed capsule, which may detect Barrett's esophagus without a standard endoscopy. It is for people who are already scheduled for an endoscopy.
This study checks whether a swallowable capsule can help find signs of Barrett’s esophagus or esophageal cancer (or related risk) before or around an endoscopy. The goal is to see if this less invasive sampling method could improve screening.
This study tests a less invasive way to check for Barrett's esophagus and esophageal cancer. Instead of a standard endoscopy, they may use a sponge-on-a-string or other simpler methods, which could be more comfortable and easier for patients.
This trial tests a new, non-endoscopic screening method for Barrett's esophagus (a condition that can lead to cancer) in veterans who do not have chronic acid reflux. It aims to find early signs of the condition using a simple swallowable device, potentially avoiding the need for a traditional endoscopy.
This study tests less invasive ways to detect high-grade dysplasia (very abnormal cells) and esophageal cancer in people with Barrett's esophagus, a condition that can increase cancer risk. It looks for these changes using cell samples taken during a routine endoscopy, which may be quicker and more comfortable than standard biopsies.
Hear when a new Barrett Esophagus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.